Ritalin and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ritalin (methylphenidate hydrochloride) and Kenalog (triamcinolone acetonide). Common drug interactions include basal cell carcinoma among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Ritalin and Kenalog. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

25 people who take Ritalin and Kenalog together, and have interactions are studied.

Ritalin and Kenalog drug interactions.

What are the common drug interactions of Ritalin and Kenalog, by gender? *:

female:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Drug ineffective
  3. Fall
  4. Limb crushing injury (crushing injury of upper limb)
  5. Night sweats (sweating in night)
  6. Pruritus generalised (generalized itching)
  7. Headache (pain in head)
  8. Injection site pain
  9. Nausea (feeling of having an urge to vomit)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

male:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Death
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Pneumonia viral
  7. Pneumonia
  8. Blood creatinine increased
  9. Hypotension (abnormally low blood pressure)
  10. Asthenia (weakness)

What are the common drug interactions of Ritalin and Kenalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Affective disorder (mental disorder)
  3. Anaemia of chronic disease
  4. Burning sensation
  5. Cataract (clouding of the lens inside the eye)
  6. Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
  7. Confusional state
  8. Depressed mood
  9. Diarrhoea
  10. Dyskinesia (abnormality or impairment of voluntary movement)

40-49:

  1. Viral upper respiratory tract infection

50-59:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Drug ineffective
  3. Fall
  4. Limb crushing injury (crushing injury of upper limb)
  5. Night sweats (sweating in night)
  6. Pneumonia
  7. Pruritus generalised (generalized itching)
  8. Injection site pain

60+:

  1. Blood creatinine increased
  2. Hypotension (abnormally low blood pressure)
  3. Pneumonia
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Weight decreased
  6. Asthenia (weakness)
  7. Cellulitis (infection under the skin)
  8. Chronic kidney disease
  9. Colitis (inflammation of colon)
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 36.00%
  2. Osteoporosis (bones weak and more likely to break): 5 people, 20.00%
  3. Abdominal Pain: 4 people, 16.00%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 16.00%
  5. Stress And Anxiety: 4 people, 16.00%
  6. Anaemia (lack of blood): 4 people, 16.00%
  7. Back Pain: 4 people, 16.00%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 16.00%
  9. Muscle Spasms (muscle contraction): 4 people, 16.00%
  10. Insomnia (sleeplessness): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and Kenalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ritalin and Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ritalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kenalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride and triamcinolone acetonide (the active ingredients of Ritalin and Kenalog, respectively), and Ritalin and Kenalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: